Tadalafil 10 MG

DRUG4 trials

Sponsors

Institute of Liver and Biliary Sciences, India, Aswan University Hospital, Seattle Gummy Company, Philip Kern

Conditions

CirrhosisErectile DysfunctionObesityPre-diabetes

Phase 1

A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers

Not yet recruitingNCT04762082

Seattle Gummy CompanyErectile Dysfunction

Start: 2025-05-01End: 2025-12-30Target: 30Updated: 2024-06-13

Phase 4

The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics

RecruitingNCT05051436

Philip KernObesity, Pre-diabetes

Start: 2021-12-13End: 2026-08-01Target: 96Updated: 2026-02-03

Unknown Phase

Tadalafil for Erectile Dysfunction in Patients With Cirrhosis

CompletedNCT03566914

Institute of Liver and Biliary Sciences, IndiaCirrhosis

Start: 2018-06-30End: 2019-12-28Updated: 2021-07-06

Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction

CompletedNCT03834610

Aswan University HospitalErectile Dysfunction

Start: 2017-10-01End: 2018-10-01Updated: 2019-02-08

Related Papers

Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial.

2021-11-1412 citations